MIRA INFORM REPORT

 

 

Report Date :

23.03.2013

 

IDENTIFICATION DETAILS

 

Name :

J P N PHARMA PRIVATE LIMITED

 

 

Registered Office :

D/10, Matru Ashish Building, Near Balbharati School, S V Road, Kandivali (West), Mumbai - 400067, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

31.03.2004

 

 

Com. Reg. No.:

11-145446

 

 

Capital Investment / Paid-up Capital :

Rs. 12.872 Millions

 

 

CIN No.:

[Company Identification No.]

U24230MH2004PTC145446

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMJ10472A

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (API’s) and Drug Intermediates (DI’s).

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (42)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 149000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record. Trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered normal for business dealings at usual trade term and condition.  

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office :

D/10, Matru Ashish Building, Near Balbharati School, S V Road, Kandivali (West), Mumbai - 400067, Maharashtra, India

Tel. No.:

91-22-28643481/ 28072182/ 67141516

Fax No.:

91-22-28640377

E-Mail :

info@jpnpharma.net

jpi@vsnl.com

Website :

www.jpnpharma.net

Location :

Owned

 

 

Plant  1 :

T-108/109, MIDC Tarapur, Taluka Palghar, Boisar, Thane - 401506, Maharashtra, India

Tel. No.:

91-2525-271296

 

 

Plant 2 :

T-11, MIDC, Tarapur, Taluka Palghar, Boisar, Thane - 401506, Maharashtra, India

Tel. No.:

91-2525-272446

 

 

DIRECTORS

 

AS ON 24.09.2012

 

Name :

Mr. Mukund Popatlal Shah

Designation :

Director

Address :

B 402, Godgrace CHS Limited, Off Marve Road, Malad (West), Mumbai – 400064, Maharashtra, India

Date of Birth/Age :

21.08.1961

Date of Appointment :

31.03.2004

DIN No.:

00288387

 

 

Name :

Mr. Jayesh Popatlal Shah

Designation :

Director

Address :

B-14, Alka Opposite N.L. High School, 19, S.V. Road, Malad (West), Mumbai – 400064, Maharashtra, India

Date of Birth/Age :

02.01.1968

Date of Appointment :

31.03.2004

DIN No.:

00288404

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 24.09.2012

 

Names of Shareholders

 

No. of Shares

 

Jayesh Shah

 

306470

Mukund Shah

 

656510

Popatlal Shah

 

100

Popatlal Shivlal Shah (HUF)

 

70600

Mukund Popatlal Shah (HUF)

 

76600

Pragna Mukund Shah

 

100

Jayesh Popatlal Shah (HUF)

 

75100

Bijal Jayesh Shah

 

90600

Jayaben Shah

 

11000

Ela Kothari

 

10

Induben Ghiya

 

10

Kashyap Kothari

 

10

Mahesh Kothari

 

10

Mamta Vasa

 

10

Pratapbhai Patel

 

10

Ramaben Patel

 

10

Urvashi Ghiya

 

10

Ketul Toliya

 

10

Nirav Kothari

 

10

Meena Kothari

 

10

Mukesh Kothari (HUF)

 

10

Mukesh Kothari

 

10

Shilpa V Patel

 

10

Bharti R Shah

 

10

Bhavna Praful Shah

 

10

Total

 

1287240

 

 

AS ON 24.09.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

82.72

Others

 

17.28

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Active Pharmaceutical Ingredients (API’s) and Drug Intermediates (DI’s).

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Bank of Baroda, IBB Branch, Mathru Ashish Building, S. V. Road Kandivali (West), Mumbai - 400067, Maharashtra, India

 

 

Facilities :

 

Secured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

Term loan

 

 

Bank of Baroda TL 374

2.550

2.530

Bank of Baroda TL 460

3.580

0.000

Bank of Baroda TL 487

1.606

0.000

On Cash Credit (Bank of Baroda)

20.702

10.412

On Export Bill Discounting (Bank of Baroda)

0.000

10.000

Bank of Baroda (Packing Credit)

6.997

0.000

Total

35.435

22.942

 

Notes:

 

Bank of Baroda Term Loan 374

Secured by first charge by way of hypothecation of Factory Premises and Plant and Machinery in favour of bank. The Outstanding loan is repayable in balance 46 installments of Rs. 0.075 Million each with floating rate of Interest. (Base Rate + 3.50% i.e 14.25% p.a. on March, 2012)

 

Bank of Baroda Term Loan-460

Secured by first charge by way of hypothecation of Factory Premises & Plant and Machinery in favour of bank. The Outstanding loan is repayable in 60 instalments of Rs. 0.075 Million each commencing from July 2012. i.e 14.25% The applicable Interest Rate is Base rate + 3.25% p.a. i.e 14.25% p.a.

 

Bank of Baroda Term Loan - 487

Secured by first charge by way of hypothecation of Factory Premises & Plant and Machinery in favour of bank. The sanctioned loan is Rs. 17.500 Millions. The loan is repayable in 59 monthly instalments of Rs.0.292 Million each and last 60th instalment of Rs.0.272 Million commencing from March, 2013. The applicable Interest Rate is Base rate + 3.25% p.a. i.e 14.25% p.a.

 

Cash Credit

Secured by first charge by way of hypothecation of stock and book debts with margin 25% of Stock and 40% on Books Debts.

 

Corporate Guarantee of JPN Pharma Private Limited to the extent of Fund Based Limit of Rs. 17.500 Millions.

 

The Cash Credit Is repayable on demand and carries interest rate Base rate + 3.50% i.e. 14.25% p.a.

 

Packing Credit / Foreign Bill Purchase

Secured by first charge by way of hypothecation of stock and book debts with margin of 25% in case of Packing Credit

 

Corporate Guarantee of JPN Pharma Private Limited to the extent of Fund Based Limit of Rs. 7.000 Private Limited

 

The Credit Is repayable on demand and carries interest rate Base rate + 1.25% i.e. 12.00% p.a.

 

 

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

K. B. Mehta and Company

Chartered Accountants

Address :

106, Unique Apartment, 1st Floor, S. V. Road, Irla, Vile-Parle (West), Mumbai – 400056, Maharashtra, India

Tel. No.:

91-22-65250201

Fax No.:

91-22-26711801

E-Mail :

Mahudi_kiran@rediffmail.com

Income-tax PAN of auditor or auditor's firm :

AABPM9871E

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,500,000

Equity Shares

Rs. 10/- each

Rs. 15.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1,287,240

Equity Shares

Rs. 10/- each

Rs. 12.872 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

12.872

12.872

10.872

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

24.317

13.877

8.471

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

37.189

26.749

19.343

LOAN FUNDS

 

 

 

1] Secured Loans

35.435

22.942

15.497

2] Unsecured Loans

19.689

15.406

11.748

TOTAL BORROWING

55.124

38.348

27.245

DEFERRED TAX LIABILITIES

0.976

0.665

0.320

 

 

 

 

TOTAL

93.289

65.762

46.908

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

35.881

32.727

28.688

Capital work-in-progress

1.704

0.000

0.000

 

 

 

 

INVESTMENT

0.012

0.012

0.012

DEFERRED TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

16.199

14.487

11.320

 

Sundry Debtors

50.734

48.851

37.969

 

Cash & Bank Balances

2.735

0.162

0.173

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

16.718

8.215

9.641

Total Current Assets

86.386

71.715

59.103

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

Sundry Creditors

21.635

25.402

 

 

Other Current Liabilities

7.934

10.812

38.286

 

Provisions

1.125

2.478

2.609

Total Current Liabilities

30.694

38.692

40.895

Net Current Assets

55.692

33.023

18.208

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

93.289

65.762

46.908

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

 

 

Other Income

 

 

 

 

 

TOTAL                                    

341.744

248.135

N.A.

 

 

 

 

 

Less

EXPENSES

 

 

Office Expenses

 

 

 

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

320.366

233.719

N.A.

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

21.378

14.416

 

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

4.338

3.648

 

 

 

 

 

 

 

PROFIT BEFORE TAX

17.040

10.768

N.A.

 

 

 

 

 

Less

TAX                                                                 

5.074

4.236

N.A.

 

 

 

 

 

 

PROFIT AFTER TAX

11.966

6.532

N.A.

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

138.874

73.774

N.A.

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw and Packing Materials

11.033

N.A.

N.A.

 

 

 

 

 

 

Earnings Per Share (Rs.)

9.30

5.07

N.A.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

3.50

2.63

N.A.

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

13.94

10.31

N.A.

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.46

0.40

N.A.

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

1.48

1.43

1.41

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.81

1.85

1.45

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS

 

Unsecured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

Loans and Advances from Related parties

13.477

8.036

Local Bill Discounting

6.212

7.370

Total

19.689

15.406

 

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24230MH2004PTC145446

Name of the company

J P N PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

D/10, Matru Ashish Building, Near Balbharati School, S V Road, Kandivali (West), Mumbai - 400067, Maharashtra, India

Email: jpi@vsnl.com

This form is for

Modification of charge

Charge identification number of the modified 

10022639

Type of charge

Immovable property

Book debts

Movable property (not being pledge)

Particular of charge holder

Bank of Baroda, IBB Branch, Mathru Ashish Building, S. V. Road Kandivali (West), Mumbai - 400067, Maharashtra, India

Email: intmum@bankofbaroda.com

Nature of description of the instrument creating or modifying the charge

Supplemental composite agreement of hypothecation of goods, bookdebts, moveable machinery and vehicles and supplemental memorandum of entry

Date of instrument Creating the charge

15.02.2012

Amount secured by the charge

Rs. 50.325 Millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Cash Credit limit  at the rate of 3.5% above Base rate,

PC / FBP / UBP at the rate of 1.25% above Base rate,

Term Loan at the rate of 3.5% above Base rate, p.a. presently with monthly rest

 

Terms of Repayment

As Per Sanction Letter

 

Margin

25% on stocks

40% on book-debts

25% on moveable machinery

30% on civil work and machinery

 

Extent and Operation of the charge

As Per Agreement

 

Short particulars of the property charged

Borrower's stocks of raw materials, stock in process, finished goods, consumable spares and packing materials, all the book - debts, machinery, vehicles, stocks and all the stores and spare parts.

 

And in Immovable Property Plot no: T-108 and T-109 containing by adm.1000 sq. mtrs. or thereabouts and factory building adm. 321.67 sq. mtrs. and 225 sq mts respectively in the Tarapur Industrial Area of MIDC, within the village limits of Pamtembhi and outside the Municipal Limits in rural area, Taluka and Registration Sub-District Palghar District and Registration District Thane.

Particulars of the present modification 

Limit enhanced from Rs.32.825 Millions to Rs.50.325 Millions

Cash credit is Rs.17.500 Millions

Term loans is Rs.8.325 Millions

Pc/fbp/fbd is Rs.7.000 Millions

Fresh term loan is Rs.17.500 Millions

 

 

FIXED ASSETS:

 

Ø  Land

Ø  Factory Premises

Ø  Plant and Machinery

Ø  Electrical Installation

Ø  Laboratory Equipment

Ø  Office Equipment

Ø  Furniture and Fixtures

Ø  Computer

Ø  Vehicle

 



 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.34

UK Pound

1

Rs. 82.56

Euro

1

Rs. 70.10

 

 

INFORMATION DETAILS

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

4

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

42

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.